Article
Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.
Gut - 1 May 2001
Tillmann H L, Chen D F, Trautwein C, Kliem V, Grundey A, Berning-Haag A, Böker K, Kubicka S, Pastucha L, Stangel W, Manns M P
Abstract excerpt
Hepatitis C virus (HCV) infection becomes chronic in more than 70% of patients, leading to end stage liver disease in about 20-30% of these patients. Apart from the virus itself, host factors that modulate the immune response are likely to be involved in determining the outcome of HCV infection. Studies on the association of human leucocyte antigens (HLAs) and HCV infection have shown inconsistent results....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.